Skip to main content

Advertisement

SpringerLink
Log in

C-Reactive Protein Measurements as a Marker of the Severity of Chronic Obstructive Pulmonary Disease Exacerbations

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease of the lungs. Acute exacerbations of COPD (AE-COPD) are a result of infectious or non-infectious instances. In our study, we aimed to determine whether serum C-reactive protein (CRP) levels are predictive indicators for disease severity and prognosis in hospitalized patients with AE-COPD. A total of 64 patients (36 regular ward and 28 ICU patients) were included in the study. Cases were identified and classified according to the Global Initiative for COPD. The first CRP test levels at acceptance at the ward or intensive care unit were counted in the study. CRP levels of patients in intensive care were significantly higher than those of patients in the regular ward. Mean values of CRP were detected to be 6.28 ± 6.53 mg/dl in the regular ward cases and 16.9 ± 12.03 mg/dl in the ICU patients (p < 0.01). The stage of COPD did not indicate a significant difference in terms of CRP values. Mean CRP values were found to be 16.02 ± 6.95 mg/dl in mortal cases and 9.76 ± 11.09 mg/dl in survivors (p < 0.01). High CRP levels were considered as a prognostic parameter and indicator of severity of AE-COPD. Increased mortality risk was found to be associated with high CRP values.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Global Initiative for Chronic Obstructive Lung Disease. 2004. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease. Updated 2004 http://www.goldcopd.com/uploads/users/files/GOLDWkshp2004Clean.pdf.

  2. Wedzicha, J.A., and G.C. Donaldson. 2003. Exacerbations of chronic obstructive pulmonary disease. Respiratory Care 48: 1204–1213.

    PubMed  Google Scholar 

  3. Reynolds, H.Y. 2004. Chronic obstructive pulmonary disease. In Principles and practice of infectious diseases, 6th ed, ed. G.L. Mandell, J.E. Bennett, and R. Dolin, 706–710. Philadelphia: Churchill Livingstone.

    Google Scholar 

  4. Johannes, M.A.D., S. Marianne, S. Dominic, L.K. Dirk, L. René, and M.J. Henk. 2010. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD. Chest 138: 1108–1115.

    Article  Google Scholar 

  5. Shameem, M., R. Bhargava, and Z. Ahmad. 2011. Association between serum C-reactive protein levels and other important predictive markers of outcome in COPD. Acta Medica Iranica 49: 18–20.

    PubMed  Google Scholar 

  6. Tascı, C., A. Balkan, N. Karadurmus, S. Inal, S. Kılıç, and M. Ozkan. 2008. The importance of serum procalcitonin levels in patients with chronic obstructive pulmonary disease exacerbations. Turkish Journal of Medical Sciences 38: 139–145.

    Google Scholar 

  7. Garcia-Rio, F., M. Miravitlles, J.B. Soriano, L. Munoz, E.D. Tauleria, and G. Sanchez. 2010. Systemic inflammation in chronic obstructive pulmonary disease: A population-based study. Respiratory Research 11: 63–75.

    Article  PubMed  Google Scholar 

  8. Peisajovich, A., L. Marnell, C. Mold, and T.W. Du Clos. 2008. C-reactive protein at the interface between innate immunity and inflammation. Expert Review of Clinical Immunology 4: 379–390.

    Article  PubMed  CAS  Google Scholar 

  9. Dinarello, C.A. 1996. The acute phase response. In Cecil textbook of medicine, 20th ed, ed. J.C. Bennett and F. Plum, 1535–1537. Philadelphia: WB Saunders.

    Google Scholar 

  10. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically—Sixth edition: Approved standard M7-A6. NCCLS, Wayne.

  11. Horan, T.C., and R.P. Gaynes. 2004. Surveillance of nosocomial infections. In Hospital epidemiology and infection control, 3rd ed, ed. C.G. Mayhall, 1659–1702. Philadelphia: Lippincott Williams & Wilkins.

    Google Scholar 

  12. Erturk, E., M. Polatlı, A. Kocabaş, N. Yıldırım, A. Gürgün, S. Saryal, and N. Kokturk. 2010. Consensus report of Turkish Thoracic Society for the diagnosis and treatment of chronic obstructive lung disease. Turkish Thoracic Journal 11(Suppl 1): S5–S63

    Google Scholar 

  13. Lacoma, A., C. Prat, F. Andreo, L. Lores, J. Ruiz-Manzano, V. Ausina, and J. Domínguez. 2011. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 6: 157–169. doi:10.2147/COPD.S16070.

    PubMed  Google Scholar 

  14. Seppa, Y., A. Bloigu, P.O. Honkanen, L. Miettine, and H. Syrjala. 2001. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Archives of Internal Medicine 161: 2709–2713.

    Article  PubMed  CAS  Google Scholar 

  15. Almirall, J., I. Bolibar, P. Toran, G. Pera, X. Boquet, X. Balanzó, et al. 2004. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 125: 1335–1342.

    Article  PubMed  Google Scholar 

  16. Lacoma, A., C. Prat, F. Andreo, and J. Dominguez. 2009. Biomarkers in the management of COPD. European Respiratory Review 18: 96–104.

    Article  PubMed  CAS  Google Scholar 

  17. Dahl, M., J. Vestbo, P. Lange, S.E. Bojesen, A. Tybjaerg-Hansen, and B.G. Nordestgaard. 2007. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 175: 250–255.

    Article  PubMed  CAS  Google Scholar 

  18. Gan, W.Q., S.F.P. Man, A. Senthilselvan, and D.D. Sin. 2004. Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and meta-analysis. Thorax 59: 574–580.

    Article  PubMed  CAS  Google Scholar 

  19. Tofan, F., M.H. Rahimi-Rad, Y. Rasmi, and S. Rahimirad. 2012. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease. Pneumologia 61: 160–162.

    PubMed  Google Scholar 

  20. Zhang, Y., H. Bunjhoo, W. Xiong, Y. Xu, and D. Yang. 2012. Association between C-reactive protein concentration and chronic obstructive pulmonary disease: A systematic review and meta-analysis. The Journal of International Medical Research 40: 1629–1635.

    Article  PubMed  CAS  Google Scholar 

  21. Mannino, D.M., E.S. Ford, and S.C. Redd. 2003. Obstructive and restrictive lung disease and markers of inflammation: Data from the Third National Health and Nutrition Examination. American Journal of Medicine 114: 758–762.

    Article  PubMed  Google Scholar 

  22. Broekhuizen, R., E.F.M. Wouters, E.C. Creutzberg, and A.M.W.J. Schols. 2006. Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61: 17–22.

    Article  PubMed  CAS  Google Scholar 

  23. Stockley, R.A., C. O'Brien, A. Pye, and S.L. Hill. 2000. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 117: 1638–1645.

    Article  PubMed  CAS  Google Scholar 

  24. Nural, S., E. Gunay, B. Halici, S. Celik, and M. Unlu. 2013. Inflammatory processes and effects of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammation 36: 66–74.

    Article  PubMed  CAS  Google Scholar 

  25. Yanbaeva, D.G., M.A. Dentener, E.C. Creutzberg, G. Wesseling, and E.F. Wouters. 2007. Systemic effects of smoking. Chest 131: 1557–1566.

    Article  PubMed  CAS  Google Scholar 

  26. Pinto-Plata, V.M., H. Mullerova, J.F. Toso, M. Feudjo-Tepie, J.B. Soriano, and R.S. Vessey. 2006. C-reactive protein in patients with COPD, control smokers and nonsmokers. Thorax 6: 23–28.

    Google Scholar 

  27. Gan, W.Q., S.F. Paul Man, and D.D. Sin. 2005. The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest 127: 558–564.

    Article  PubMed  Google Scholar 

  28. Lowy, F.D. 1998. Staphylococcus aureus infections. The New England Journal of Medicine 339: 520–532.

    Article  PubMed  CAS  Google Scholar 

  29. Kadioglu, A., and P.W. Andrew. 2004. The innate immune response to pneumococcal lung infection: The untold story. Trends in Immunology 25: 143–149.

    Article  PubMed  CAS  Google Scholar 

  30. Sethi, S., C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T.F. Murphy. 2008. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 177: 491–497.

    Article  PubMed  Google Scholar 

  31. Murphy, T.F. 2006. The role of bacteria in airway inflammation in exacerbations of chronic obstructive pulmonary disease. Current Opinion in Infectious Diseases 19: 225–230.

    Article  PubMed  Google Scholar 

  32. Peng, C., C. Tian, Y. Zhang, X. Yang, H. Fan, and Y. Feng. 2013. C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease. The American Journal of the Medical Sciences 345: 190–194.

    Article  PubMed  Google Scholar 

Download references

Conflicts of Interest

The authors declare that they have no conflicts of interest in relation to this article.

Funding

No financial support was taken for the study.

Author information

Authors and Affiliations

  1. Department of Chest Diseases, Izmir Chest Diseases and Thoracic Surgery Hospital, Izmir, Turkey

    Gulistan Karadeniz, Gulru Polat & Melih Buyuksirin

  2. Department of Clinical Microbiology and Infectious Diseases, Izmir Chest Diseases and Thoracic Surgery Hospital, 1703 S. No.42 D.3, 35600, Karsiyaka, Izmir, Turkey

    Gunes Senol

Authors
  1. Gulistan Karadeniz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gulru Polat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gunes Senol
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Melih Buyuksirin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gunes Senol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karadeniz, G., Polat, G., Senol, G. et al. C-Reactive Protein Measurements as a Marker of the Severity of Chronic Obstructive Pulmonary Disease Exacerbations. Inflammation 36, 948–953 (2013). https://doi.org/10.1007/s10753-013-9625-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-013-9625-z

KEY WORDS

Search

Navigation